Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder
- PMID: 32435448
- PMCID: PMC7225792
- DOI: 10.1177/2045125320916655
Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder
Abstract
Background: Abnormal expression of inflammatory cytokines in major depressive disorder (MDD) suggests the activation of an inflammatory process. The pattern of alterations in cytokine levels is still ambiguous. The present study aimed to evaluate interleukin-7 (IL-7) and interleukin-10 (IL-10) for their involvement in the pathophysiology of MDD and determine their relationships with depression risk.
Methods: The study included 166 medication-free subjects: 84 MDD patients and 82 sex- and age-matched healthy controls (HCs). A qualified psychiatrist diagnosed patients and evaluated controls based on the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). Hamilton depression rating scale (Ham-D) was used to measure the severity of depression in MDD patients. Serum IL-7 and IL-10 levels were measured using enzyme-linked immunosorbent assay (ELISA) kits.
Results: Compared with HCs, the serum levels of IL-7 were significantly decreased, whereas that of IL-10 increased in MDD patients. Moreover, the severity of depression is correlated with the altered levels of IL-7 and IL-10 in MDD patients. We found a negative correlation between IL-7 and Hamilton depression rating (Ham-D) scores (r = -0.580, p < 0.05), whereas there was a positive correlation between IL-10 and Ham-D scores (r = 0.555, p < 0.05).
Conclusions: The altered levels of serum IL-7 and IL-10 in MDD patients may represent a homeostatic mechanism that enhances the inflammatory process during depression. The alterations of these cytokine levels in MDD and their association with the severity of depression support them as promising, but there may still be controversial factors for understanding the pathophysiology of depression.
Keywords: IL-10; IL-7; MDD; interleukin-10; interleukin-7; major depressive disorder.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Figures



Similar articles
-
Higher serum interleukin-12 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.Health Sci Rep. 2022 Dec 24;6(1):e1005. doi: 10.1002/hsr2.1005. eCollection 2023 Jan. Health Sci Rep. 2022. PMID: 36582626 Free PMC article.
-
Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study.PLoS One. 2022 Nov 21;17(11):e0276619. doi: 10.1371/journal.pone.0276619. eCollection 2022. PLoS One. 2022. PMID: 36409748 Free PMC article.
-
Elevated Serum IL-2 Levels are Associated With Major Depressive Disorder: A Case-Control Study.Clin Pathol. 2023 Jun 15;16:2632010X231180797. doi: 10.1177/2632010X231180797. eCollection 2023 Jan-Dec. Clin Pathol. 2023. PMID: 37360518 Free PMC article.
-
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.Mol Psychiatry. 2020 Feb;25(2):339-350. doi: 10.1038/s41380-019-0474-5. Epub 2019 Aug 19. Mol Psychiatry. 2020. PMID: 31427752
-
The role of IL-33 in depression: a systematic review and meta-analysis.Front Psychiatry. 2023 Nov 1;14:1242367. doi: 10.3389/fpsyt.2023.1242367. eCollection 2023. Front Psychiatry. 2023. PMID: 38025419 Free PMC article.
Cited by
-
Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder.Sci Rep. 2024 Jan 18;14(1):1652. doi: 10.1038/s41598-024-51932-9. Sci Rep. 2024. PMID: 38238514 Free PMC article.
-
Comprehensive view of suicide: A neuro-immune-endocrine approach.World J Psychiatry. 2025 Feb 19;15(2):98484. doi: 10.5498/wjp.v15.i2.98484. eCollection 2025 Feb 19. World J Psychiatry. 2025. PMID: 39974471 Free PMC article. Review.
-
Associations Between Tenascin-C and Testosterone Deficiency in Men with Major Depressive Disorder: A Cross-Sectional Retrospective Study.J Inflamm Res. 2021 Mar 16;14:897-905. doi: 10.2147/JIR.S298270. eCollection 2021. J Inflamm Res. 2021. PMID: 33758529 Free PMC article.
-
One year follow-up on a randomized study investigating serratus anterior muscle and pectoral nerves type I block to reduced neuropathic pain descriptors after mastectomy.Sci Rep. 2023 Mar 21;13(1):4591. doi: 10.1038/s41598-023-31589-6. Sci Rep. 2023. PMID: 36944694 Free PMC article. Clinical Trial.
-
Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh.PLoS One. 2021 Jul 27;16(7):e0255379. doi: 10.1371/journal.pone.0255379. eCollection 2021. PLoS One. 2021. PMID: 34314447 Free PMC article.
References
-
- Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53: 649–659. - PubMed
-
- Nolen-Hoeksema S, Girgus J. The emergence of gender differences in depression during adolescence. Psychol Bull 1994; 115: 424–443. - PubMed
-
- Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197–223. - PubMed
-
- Friedman A. Jump-starting natural resilience reverses stress susceptibility. Science 2014; 346: 555–555. - PubMed
LinkOut - more resources
Full Text Sources